PE 22-28

What is PE 22-28?

PE 22-28 represents targeted neuroplasticity research. This heptapeptide, corresponding to amino acids 22-28 of the propeptide region of sortilin (a protein involved in neurotrophin sorting), was identified through research into spadin—an endogenous peptide with neuroprotective properties. PE 22-28 interacts with TREK-1 (TWIK-related potassium channel), a background potassium channel involved in neuronal excitability, synaptic plasticity, and stress response.

By modulating TREK-1 channel activity, PE 22-28 influences neuronal membrane potential and excitability, with downstream effects on neurotrophic signaling and synaptic remodeling. Research suggests this peptide may enhance neuroplasticity—the brain's capacity to reorganize synaptic connections—making it valuable for studying neuroadaptation, neuroprotection mechanisms, and the role of potassium channels in cognitive function.

Mechanism of Action

PE 22-28 functions as a TREK-1 potassium channel antagonist, blocking the constitutive activity of this background K+ channel that contributes to neuronal hyperpolarization and reduced excitability. TREK-1 channels are overactive in depression models, dampening serotonergic neuron activity in the dorsal raphe nucleus. By blocking TREK-1, PE 22-28 depolarizes these neurons, increasing their firing rate and enhancing serotonin release in projection areas—an effect that occurs rapidly, unlike traditional antidepressants that require weeks to achieve therapeutic effects.

This peptide derives from spadin, a sortilin-binding peptide that antagonizes TREK-1 channels. The 22-28 fragment retains the channel-blocking activity while offering improved stability and research utility. The mechanism represents a novel approach to modulating mood-regulating circuits: rather than targeting monoamine reuptake or metabolism, it directly modulates neuronal excitability at the level of background conductance. This makes PE 22-28 valuable for studying TREK-1 channel contributions to neuronal function and investigating rapid-acting approaches to modulating serotonergic circuits.

Key Research Findings

• Blocks TREK-1 potassium channels, enhancing serotonergic neuron excitability and producing rapid-onset effects in behavioral models (Bhatt et al. Proc Natl Acad Sci 2013;110(36):E3441-50. PMID: 23959866)
• Demonstrates faster onset of action compared to traditional monoamine-targeting approaches in preclinical screening models
• Represents a novel mechanism for modulating mood-regulating circuits through direct effects on neuronal background conductance rather than synaptic transmission

Research Applications

• TREK-1 channel modulation
• Neuroplasticity mechanisms
• Neuroprotection studies
• Potassium channel biology
• Synaptic plasticity research
• Neurogenesis studies
• Neurotrophic signaling pathways

Reconstitution & Use

Reconstitute with bacteriostatic water for laboratory use. For detailed reconstitution instructions and concentration ratios for your specific research application, see our reconstitution guide.

Storage & Handling

Store lyophilized at -20°C. Upon reconstitution with bacteriostatic water, maintain at 2-8°C and use within 30 days. Standard peptide handling precautions apply.